chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received the ZOSTAVAX vaccine on 08/28/17, did not pay attention and just realized in the evening  of 09/05/17 redness around the injection site. The redness is approximately 3 quarter sizes big, no fever, no itching , no soreness, no inflammation. Asked patient to watch for any change and may take or apply Benadryl  if needed.
REVACCINATED/PATIENT RECEIVED 2 DOSES OF THE JANSSEN COVID19 VACCINE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a 50 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 202A21A, expiry: UNKNOWN) dose was not reported, administered on APR-2021, and dose was not reported, administered on 25-JUN-2021 13:15 for prophylactic vaccination. No concomitant medications were reported. On 25-JUN-2021, the subject experienced revaccinated/subject received 2 doses of the janssen covid19 vaccine. On 25-JUN-2021, the subject experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the revaccinated/patient received 2 doses of the janssen covid19 vaccine and off label use was not reported. This report was non-serious.
THE PATIENT CONTRACTED SHINGLES AFTER RECEIVING THE SECOND DOSE OF THE SERIES OF TWO. THE SYMPTOMS SHOWED UP 5 DAYS AFTER RECEIVING THE VACCINE.
Chronic constipation and chronic flu like symptoms including fatigue, weakness, nausea, migraine, malaise
pt vaccinated with an expired dose; This case was reported by a physician via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (batch number KM72C, expiry date 18th June 2022) for prophylaxis.   On 22nd June 2022, the patient received Havrix. On 22nd June 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 22-JUN-2022 Reporter's Comment: Gastroenterologist reported that the patient was vaccinated today (day of reporting) with an expired dose of Havrix.  The reporter consented to follow-up. Additional Supportive Information:  The patient received a dose of Havrix vaccine which was already expired, which led to expired vaccine used.
Information has been received from a healthcare worker referring to an unspecified number of patients of unknown ages and gender. On 18-FEB-2015 the patients were vaccinated with improperly stored doses of (Oka/Merck) VARIVAX (lot#, dosage and route unspecified). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Flu like symptoms. Achey, tired, no energy. Really crappy. Came home from work and went to bed.
Dizziness / Light-headed; Lost of strength; Heart palpitations; Lack of sleep; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 31 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 14Sep2021 (Batch/Lot number: unknown) at the age of 31 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Asthma" (ongoing), notes: Verbatim: Asthma. The patient's concomitant medications were not reported. Vaccination history included: Flu shot (when he was a teenage to the flu shot,other details other than it was to the flu vaccine.). The following information was reported: DIZZINESS (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Dizziness / Light-headed"; ASTHENIA (non-serious) with onset 14Sep2021, outcome "not recovered", described as "Lost of strength"; PALPITATIONS (non-serious) with onset 14Sep2021, outcome "recovered" (Sep2021), described as "Heart palpitations"; INSOMNIA (non-serious) with onset Sep2021, outcome "not recovered", described as "Lack of sleep". Therapeutic measures were not taken as a result of dizziness, asthenia, palpitations, insomnia.  Additional information: Then, the heart palpitations stopped. However, he continued to have improper sleep, lightheadedness, dizzy spells, and loss of strength. This is causing him to to be able to work. This started after he got the first dose, 14Sep2021. He clarified the dizziness, light-headed, had lost of strength and energy, he also had heart palpitations, and lack of sleep started shortly after getting the vaccine on the same day. He confirmed the dizzy spells are not as bad. Heart palpitations: These are completely gone. It stopped the third day after the vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Rapid, irregular heartbeat.   Apple watch up to 130 bpm.    LIghtheaded.   Lasted 20 minutes.   Continues to date.
Pruritis; Urticaria Severe itching wrists, lower arms. Severe itching lower legs with swelling of legs.; Urticaria; Pruritis; UrticariaSevere itching wrists, lower arms.Severe itching lower legs with swelling of legs.; Pruritis; Urticaria Severe itching wrists, lower arms. Severe itching lower legs with swelling of legs.; This is a spontaneous report from a contactable consumer (patient). A 69-year-old male patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EN6199) via an unspecified route of administration, administered in left arm on 21Mar2021 at 11:45 (at the age of 69-year-old) as dose 2, single for COVID-19 immunization. The patient medical history includes hypertension. Concomitant medications include omeprazole, amlodipine besylate and diphenhydramine hydrochloride (BENADRYL) taken in two weeks. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9261) via an unspecified route of administration, administered in left arm on20Feb2021 at 12:30 (at the age of 69-year-old) as dose 1, single for COVID-19 immunization. Patient had no known allergies. Patient received no any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination patient was not diagnosed with COVID-19. On 22Mar2021, the patient experienced pruritus; urticaria severe itching wrists, lower arms, severe itching lower legs with swelling of legs. Events resulted in Doctor or other healthcare professional office/clinic visit. Treatment was initiated with Kenalog 40 mg injection. Since the vaccination, patient was not tested for COVID-19. The outcome of the events was not recovered.  No follow-up attempts possible. No further information expected.
Patient describes extensive pain, more than when she had previous shot. Feels like her "arm was punched".
Likely Seizure Activity: inappropriate laughter with unidirectional gaze and unresponsiveness for about 3-5 mins per mom with post-ictal state for about 1-2 mins followed by headache.
Arm was a little red but didn't hurt woke up 2nd day after, shot and all my joints were very swollen and painful. Was exercising 3 days a week- 2 to 3 hrs. can't do 1 full class now. Weak muscle- just don't feel the same as I did before I had it.
Pregnant PT; flu; This is a spontaneous report received from a non-contactable reporter(s) (Other HCP).  A female patient (pregnant) received BNT162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: MATERNAL EXPOSURE TIMING UNSPECIFIED (non-serious), outcome "unknown", described as "Pregnant PT"; INFLUENZA (non-serious), outcome "unknown", described as "flu".  Additional information: The patient age is 30-34 years. Pregnant PT reported she received COVID vaccine, and she got her booster in November, and she got her flu back in September.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Case number PHEH2013US014931, is an initial spontaneous report received from a nurse on 10 Jul 2013. This report refers to an 18 years old adult female patient. Her medical history and concomitant medications was not reported. She received only with Men CYW-135 liquid conjugate vaccine component of MENVEO (batch number: X11032) intramuscularly on 08 Jul 2013. She did not received Men A lyophilized conjugate vaccine component of MENVEO. No adverse event was reported following this administration error. No additional information was available.
Left forearm- JYNNEOS vaccination error no wheal. Repeat dose with 0.5 SQ.
pt recv vax & exp a rash that itches terribly;pt reported itching was worse @ noc & has little pimples on legs, stomach & arms that have lasted for weeks;skin has a black & blue vein-like appearance;pt sought unspecified attention;
Pt presented with a rash that is healing after the first shot. Pt experienced itching and heat the day after the first shot at a location on the lower abdomen near the hip bone. Pt didn't  experience any fever. So at the area of the itching, a rash developed about a week after the shot. Pt has been taking Benadryl  and hydrocortisone  cream to ease the itching since then. Pt continued to itch the area if she didn't have any relief from the hydrocortisone.  On 6-14-2021. pt received the 2nd shot in the right arm. She was  instructed  to come into the pharmacy or call us as needed to update us on her condition.
Patient c/o redness, lumpy  and swelling at injection site.  Painful to touch, soreness.    Evaluated by provider, marked area for observation of increased redness.  Provided recommendations of ER if symptoms  get worse or develop fever, streaks on arm.
small red welt appeared at injection site; small red welt appeared at injection site; arm pain returned; arm pain at site of injection; This is a spontaneous report from a contactable consumer (patient). A 43-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number EL9262), via an unknown route of administration on 29Jan2021 at 17:00 (at the age of 43-years-old) as a single dose in the left arm for COVID-19 immunization. The patient's medical history was not reported. The patient had allergies to sulfa. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. Concomitant medications were not reported (did not have other medications in two weeks). The patient did not receive other vaccines within 4 weeks prior to vaccination. On 29Jan2021, the patient initially experienced arm pain at the site of injection; on 06Feb2021 at 08:00 (day 8 post vaccination) the patient experienced a small red welt at the injection site and arm pain returned. The patient did not receive any treatment for the events. The clinical outcome of the event vaccination site pain was recovered within approximately 36 hours; vaccination site erythema and vaccination site reaction was resolved on day 9; and pain in arm was recovering.
Subsequent to receiving varicella virus vaccine live the pt developed a lesion. Two days later the pt presented to a physician and was diagnosed with chickenpox. Five days later the pt recovered.
Diagnosed as Bell's Palsy by MD on 10/30/17. Partial facial paralysis.
Minutes after DTaP vaccine daughter spiked fever within an hour came home and she stopped breathing, father blew into her mouth and she was breathing normal, still have fever and was extremely lethargic with fever for 3 days. Day 4 woke up and was a different child. She wasn't making eye contact, stopped giggling and saying words like momma dadda baba, she regressed. Now resulting in early intervention with speech and OT, when prior the child was advanced. Diagnosed with sensory processing disorder.
A rash on her left leg that was itchy and spread more; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (A rash on her left leg that was itchy and spread more) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038k20a and 013m20a) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-Jan-2021, the patient experienced RASH PRURITIC (A rash on her left leg that was itchy and spread more). At the time of the report, RASH PRURITIC (A rash on her left leg that was itchy and spread more) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   Concomitant medication was not reported.  Treatment included unspecified cream.   This case was linked to MOD-2021-027643.
- App 1 hr after shot pt called w/6 cm red, inflamed, high raised, warm to touch, circle w/hives. Pt took .25 mg BENADRYL & ibu/200 mg. - 2 hrs later 2 cm circumference very painful hives almost gone still raised. - 4 hrs later - swelling raised & painful same decreased redness.
1.Unknown initial fever onset the first 48 hrs (Dr instructed folloing 48 hrs to immediately start Tylenol administration every 4-6 hrs.) 2. Approx 96 hrs post jab, Injection site severe swelling, heat "my leg is on fire", and redness.  Lethargic, facial adema, headache, fussy, irritable, and loss of appetite.  (Note Unknown facts: a)exact site adverse reaction onset unknown because we didn't see his leg after his bath the night before (Which had had made a point to "check it then") until after we picked him up from school the following day and he was complaining about his leg before dinner and b)sinus/ear infection as he was started on 21 days of antibiotic the same day as the jab due to CT scan showing sinuses full.) 3. For the following 2 days it was swollen and swelling of his whole thigh was the same, the injection site 'raised' swelling went down and the rash began to "spread out" and became less bright red like it was disapating. 4. 8 days after the jab he was "back to normal" as far as we currently know. I TOOK PICTURES-if you need them let me know.
Headache, Myalgia, Arthralgia, Chills, Fatigue and injection site soreness.  Narrative: Day 1- mild injection site pain/soreness day 2-Chills, headache,fatigue and myalgia.
localized reaction distal to injection site(whihc was on right deltoid) extending about 6 cm with induration to inner bicep.  Has minimal warmth, not too suspicious for cellulitis, looked to be hypersensitivity reaction with localized wheal/hive formation.  Covering for infection due to appearance though.  Xyzal 5 mg daily also.
Extensive hives noted 2 days after vaccine admin. to trunk and legs. On day 3, she also had hives to R arm around injection site. None to L arm. Rash resolved over next few days with antihistamine.
3/11/2021 Patient presented with severe upper back muscle spasms and shortness of breath for the last 2 days. Diagnosed with pneumonia and hypoxia, confirmed by imaging. Covid test negative on admission.
Began showing a rash starting at neck then by 3pm it was full body and temp of 101.9 was taken. I called Dr. and they said no problem it was a reaction I called back at 3 pm when temp reached 102 and my child was nauseous and lethargic at 8 pm I called and they said watch him closely through the night and bring him a 8 am to Dr. office unless breathing stopped or became labored before that point or fever reached 104 or higher. At this point he was sleeping hard with a 102 fever and very tired but responsive. At this appt we were tested for strep and Scarlett Fever which were both positive. we were given antibiotics for these illnesses. After 7 days on antibiotic March 17th 2015  my child began running a high temperature of 100.2 vomitting and began diarrhea which has continued on till 03/22/2015 with no relief we will be seeing Dr. tomorrow.
I have a headache, fever, chills, exhausted. Now I have covid arm. My arm is itchy, swollen, pain, and have slight rash.
Narrative: Monitor noticed pt. had red, blotchy welt and redness in Right arm up to Right lower neck. This is the arm where the vaccine was administered. Pt. states that recently his skin has been red in appearance. He has no history of allergies. This is his second dose of the Pfizer Covid vaccine and he had no previous reaction during the first Pfizer vaccine. Pt. denied any breathing difficulty. Vital Signs: 13:05 HR: 86, BP: 134/84, : RR 16 Temp, 37.2, O2 Sats 98%. 13:12: HR: 88. BP:  114/74 13:19 HR 87, BP: 115/74, RR 16 At 13:23 Pt. felt well enough to leave clinic on own. Encouraged patient to walk around on facility campus 10-15 minutes before returning to his car. Erythema on arm appeared decreased and improved. No meds were given.
severe head ache; A temperature of 101.4F; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe head ache) and PYREXIA (A temperature of 101.4F) in a 68-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Jan-2021, the patient experienced HEADACHE (severe head ache) and PYREXIA (A temperature of 101.4F). At the time of the report, HEADACHE (severe head ache) and PYREXIA (A temperature of 101.4F) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  No treatment details was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
Started out with numbness in rectal area, then feet, then genital area.  On October 12 patient saw local PA.  The following week, she saw a FNP.  Blood tests were done.  MRI was done about a month later which showed bulging discs in back.  In February she saw a neurologist, who consulted with an internist, and both concurred that she probably had mild GBS.  All other blood tests had come back normal.  At this point, which is 5 months following the flu vaccination, patient still has numbness, tingling in her feet.
REPORTED TOUNGE SWELLING,  SWELLING ABOVE B WRIST W/ TIGHTNESS FEELING AND PAIN.   11:30 AM;  RECEIVED BENADRYL 50 MG IM WITH MINIMUM.   12:00 RECEIVED SOLUMEDROL 125 MG IM  12:30:  REPORTED PAIN AND TIGHTNESS TO B WRIST HAS IMPROVED
blacked out; This is a spontaneous report from a non-contactable consumer or other non hcp (Patient). A patient of unspecified age and gender received second dose of bnt162b2 (BNT162B2, Batch/Lot number was not reported, Expiry date: unknown), via an unspecified route of administration on 30Jun2021 at 10:15 as DOSE 2, SINGLE for covid-19 immunisation. Patient historical vaccine included received first doe of bnt162b2 (BNT162B2, Batch/Lot number was not reported, Expiry date: unknown), via an unspecified route of administration on unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 30Jun2021 at 10:30, The patient experienced blacked out for 15 minutes after the second injection. I blacked out for 15 minutes when I got home which had been about 26 minutes after I got the shot. The outcome of the event was unknown.
Flu vaccine (Fluzone) was given 12/11/03 AM. In the afternoon, 12/11/03, around 5 PM after 1 hour nap, started feeling dizzy and having vertigo on and off. These symptoms continued and reported on 12/12/03. Ringing in the ear and fullness in the ear is reported.
I woke up the next morning with a little puffiness in my face, my eyes and my cheeks
After my first shot, I started having ringing in my ear, especially when I lay down.  It has continued since my second shot on April 9, 2021; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on an unknown date in 2021 and also second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration on 09Apr2021 at 13:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to medications, food, or other products. Concomitant medications included levothyroxine .075 mcg daily (MANUFACTURER UNKNOWN) for unspecified indication and unknown start date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021, after first dose, the patient experienced ringing in the ear, especially when lay down. It had continued since the second shot which had taken on 09Apr2021. The patient did not receive any treatment for the event. The clinical outcome of the event ringing in the ear was not recovered, at the time of this report.   No follow-up attempts are needed. No further information is expected.
pt recv vax & while getting off commode could not support weight & fell;began having diff walking, mom states all of a sudden crippled;pt taken to MD p/CAT & x-rays pt adm to hosp;lt side paralysis, drop face & arm;c/o pain in lower back;